American Well Co. (NYSE:AMWL) Given Consensus Recommendation of “Hold” by Brokerages

American Well Co. (NYSE:AMWL) has earned a consensus rating of “Hold” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $11.90.

A number of brokerages have recently commented on AMWL. Stifel Nicolaus boosted their price objective on shares of American Well from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 13th. Needham & Company LLC reissued a “hold” rating on shares of American Well in a research report on Thursday, February 13th. Truist Financial boosted their price objective on shares of American Well from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, February 14th. Wells Fargo & Company raised shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price target on the stock in a research report on Monday, January 13th. Finally, Morgan Stanley dropped their price target on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th.

Insider Activity at American Well

In other news, insider Phyllis Gotlib sold 4,781 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.80, for a total value of $42,072.80. Following the completion of the transaction, the insider now owns 147,998 shares of the company’s stock, valued at approximately $1,302,382.40. This represents a 3.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders have sold 5,219 shares of company stock worth $46,454. Corporate insiders own 12.80% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Compagnie Lombard Odier SCmA bought a new position in American Well in the 4th quarter valued at approximately $45,000. BNP Paribas Financial Markets bought a new position in American Well during the 3rd quarter worth approximately $95,000. OMERS ADMINISTRATION Corp bought a new position in American Well during the 4th quarter worth approximately $76,000. PDT Partners LLC bought a new position in American Well during the 3rd quarter worth approximately $107,000. Finally, Walleye Capital LLC bought a new position in American Well during the 3rd quarter worth approximately $167,000. Institutional investors own 56.05% of the company’s stock.

American Well Stock Up 3.0 %

American Well stock opened at $8.20 on Tuesday. The stock has a market capitalization of $128.03 million, a PE ratio of -0.59 and a beta of 1.18. American Well has a twelve month low of $5.00 and a twelve month high of $18.80. The company has a 50 day moving average of $9.97 and a 200-day moving average of $9.32.

American Well (NYSE:AMWL) last released its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) earnings per share for the quarter, beating the consensus estimate of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. Equities analysts anticipate that American Well will post -9.34 EPS for the current fiscal year.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.